Target intelligence / Profile preview

Colonic bacterial fermentation

Molecular classification
Other
01

Overview

Colonic bacterial fermentation refers to the anaerobic breakdown of dietary carbohydrates and proteins by the microbiota in the human colon[1][3][4][5]. This process generates primarily short-chain fatty acids (such as acetate, propionate, and butyrate), which maintain colonic health by fueling colonocytes, modulating inflammation, and supporting absorption of water and minerals[1][2]. Gas production (hydrogen, methane, carbon dioxide) is also a product of fermentation[2]. Disruptions or imbalances in this fermentation can be linked to gastrointestinal disorders, including colorectal cancer and inflammatory bowel diseases[2][3]. Key clarification: "Colonic bacteria-mediated fermentation" is a broad physiological process, not a defined molecular target. It is a metabolic function performed by microbial communities, not a specific protein, receptor, or enzyme. Therefore, it is not considered a canonical drug target and its use as a specific target entry is incorrect[1][2][3][4][5].

Other names
Colonic fermentationColonic bacterial metabolismColonic microbiota fermentationColonic microbial fermentationGut fermentation
02

Biological functions

Energy harvest from undigested foodShort-chain fatty acid (SCFA) productionGut homeostasis maintenanceModulation of immune responseRegulation of water and electrolyte absorption
03

Disease associations

Colorectal cancerUlcerative colitisIrritable bowel syndromeOther gastrointestinal diseasesInfection (when microbiota disturbed)
04

Safety considerations

Excessive proteolytic fermentation products may be toxic (amines, phenols, indoles, H2S)Imbalance may contribute to gut inflammation and carcinogenesis
05

Biomarkers

Short-chain fatty acid levels (acetate, propionate, butyrate)Breath H2 or CH4 (gastrointestinal fermentation diagnostics)

Beyond the preview

Go deeper on Colonic bacterial fermentation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonic bacterial fermentation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call